We'll have a cure for cancer within a year, scientists claim

T-Cell illustration

Modal Trigger Shutterstock

Phage display allows for the identification of certain types of cells.

The problem is, Luca explained, numerous good and bad cells look alike and it's hard to match the cancer-killer toxin for a specific kind of cancer.

One of the key components to MuTaTo's success, claims AEBi, is the treatments use of a combination of multiple cancer-targeting peptides for each cancer cell at the same time and delivered along with a strong peptide toxin that specifically kills cancer cells.

Aridor was quoted as saying the company's first target is lung cancer and that it's working on others.

Asian Cup finalists Qatar face disqualification in eligibility storm
The 22-year-old Ali is widely listed to have been born in Sudan, but that could not immediately be verified. Sanchez said Qatar players delivered telling performances, adapting to change in team tactics with flair.

Morad said the company's initial efforts involved attempting to find "individual novel peptides for specific cancers".

"Instead of attacking receptors one at a time, we attack receptors three at a time", he continued. "Think of the arms of an octopus". Think of traditional chemotherapy like a grenade that annihilates anything in its path, albeit a rapidly proliferating cancer cell or neighboring healthy cell.

A team of Israeli scientists claim to have discovered a treatment for cancer that they believe they will turn into a cure within the next year, The Jerusalem Post reported late Monday night.

It's hard to know exactly what he's basing such a claim on.

Captain Marvel "Future of World" Teaser Trailer
To be fair, it does also seem as if, whether or not Goose just stole the show, this is still a movie no one wants to miss. And if the Avengers are going to need to undo Thanos' Snap, travelling to the past may come in useful.

The company has not yet published any clinical evidence showing this treatment works in humans. However, preclinical trials have been "very good".

"It is not really fair for them to announce something like this without really properly vetting it, without peer-reviewed publications or with a clinical trial", said Moffit Cancer Center researcher Vince Luca. "If this group is just beginning clinical trials, they may well have some hard experiments ahead".

Morad says most cancer treatments that fail do so because the cancer mutates, rendering treatment that was once effective, obsolete.

He added: "My colleagues here at American Cancer Society tell me phage or peptide display techniques, while very powerful research tools for selecting high affinity binders, have had a hard road as potential drugs".

Foxconn U-turns on $10bn Wisconsin factory after call with Trump
That news was seen as a setback for Mr Trump, who has made reviving the manufacturing sector a priority. On Wednesday, however, Foxconn said that it would no longer be building that factory after all.

"But based on the information available the claim that it will provide a "complete cure for cancer" is unfounded", he said. It is certainly possible this approach may work. And not just a cure for certain forms of cancer, but a complete cure for the deadly disease. "We are living in an era where many exciting advances are impacting the care of patients with cancer", Lichtenfeld went on.

Latest News